Point72 Asset Management’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-848,454
Closed -$6.23M 1838
2024
Q4
$6.23M Buy
848,454
+843,239
+16,169% +$6.19M 0.01% 639
2024
Q3
$39.1K Sell
5,215
-12,385
-70% -$92.8K ﹤0.01% 1168
2024
Q2
$157K Sell
17,600
-14,900
-46% -$133K ﹤0.01% 1032
2024
Q1
$329K Buy
32,500
+24,500
+306% +$248K ﹤0.01% 1106
2023
Q4
$80.5K Buy
8,000
+4,900
+158% +$49.3K ﹤0.01% 1238
2023
Q3
$29K Sell
3,100
-508,500
-99% -$4.76M ﹤0.01% 1552
2023
Q2
$12.5M Sell
511,600
-1,171,500
-70% -$28.7M 0.04% 461
2023
Q1
$39.2M Buy
+1,683,100
New +$39.2M 0.12% 200
2022
Q4
Sell
-54,496
Closed -$1.05M 1423
2022
Q3
$1.05M Buy
+54,496
New +$1.05M ﹤0.01% 837
2022
Q1
Sell
-2,055,100
Closed -$86M 1304
2021
Q4
$86M Buy
2,055,100
+2,033,400
+9,371% +$85.1M 0.34% 56
2021
Q3
$944K Buy
+21,700
New +$944K ﹤0.01% 809